Loan Interest Rate Form, dated May 24, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC
Exhibit 10.2
LoanAdvanceTM Interest Rate Form
STEP 1. ACCOUNT INFORMATION |
Non-Purpose Loan Account Number 3ZT047968 |
STEP 2. INTEREST RATE ACKNOWLEDGEMENT |
The undersigned (Borrower) has executed a LoanAdvance Lending Agreement (the Agreement) with Pershing LLC (Pershing). Pursuant to which Borrower has access to a line of credit collateralized by the value of securities held in Borrowers brokerage or separately managed account pledged by the Borrower (the Account). The Account is carried by Pershing as clearing broker pursuant to a clearing agreement between Pershing and your introducing firm. This Interest Rate Acknowledgement Form constitutes a supplement to the Agreement and shall be subject to and interpreted in accordance with the terms and conditions thereof.
The rate of interest charged on any credit extended in the Account is a floating rate based on the Base Rate* and may fluctuate over time. In addition, if your rate is based on the interest rate schedule provided by your financial organization, the rate may be higher or lower in the future depending on the aggregate outstanding loan amount, and any such change may be made without prior notice to Borrower. All rates described herein may be changed without prior notice to Borrower. In accordance with Paragraph 10 of the Agreement, regardless of the underlying Base Rate, interest charged in any credit extended in a LoanAdvance account may never exceed a rate equal to 3 percentage points above the Prime Rate as published in The Wall Street Journal.
STEP 3. INTEREST RATE |
Subject to the foregoing, the rate of interest that will be charged on any credit extended in the Account is equal to:
SELECT ONE | BASE RATE* | +/-(SELECT ONE) | SPREAD | TOTAL RATE | ||||||||||||||||||
| Federal Funds Target (Upper Limit) | 5.50 | % | Plus | Minus | 1.75 | = | 7.25 | % | |||||||||||||
|
|
| ||||||||||||||||||||
| Prime | % | Plus | Minus | = | % | ||||||||||||||||
|
|
| ||||||||||||||||||||
| Other: | % | Plus | Minus | = | % | ||||||||||||||||
|
|
|
| |||||||||||||||||||
| Interest Rate Schedule Provided by my Financial Organization |
*Base Rate is determined by your financial organization and may be based on Fed Funds Target, Prime Rate as published in The Wall Street Journal or another benchmark and may fluctuate over time.
STEP 4. RESTRICTED/CONTROL STOCK DISCLOSURE |
1. | Is the undersigned a control person of any publicly held organization? |
| Yes |
| No | |||||
2. | Are any of the shares subject to a control provision? |
| Yes |
| No |
If you answered yes to question 2 above, please provide details below:
NUMBER OF SHARES | NAME OF COMPANY | SYMBOL | ||
| ||||
| ||||
| ||||
|
© 2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners. | PAGE 1 OF 2 FRM-LA-DIS-ACK-10-21 |
LoanAdvance Interest Rate Form | Non-Purpose Loan Account Number 3ZT047968 |
STEP 5. SIGNATURES |
By signing below, Borrower acknowledges receipt of a completed copy of this Form, as well as any tiered interest rate schedule, if applicable. Borrower further acknowledges their understanding and acceptance of the terms disclosed herein and attests to the accuracy of the information provided.
Primary Account Owner | ||
Print Name | Date | |
ANDREW SIMS | 05-24-2024 | |
Signature | ||
/s/ ANDREW SIMS | ||
Additional Account Owner | ||
Print Name | Date | |
MARC HEDRICK | 05-24-2024 | |
Signature | ||
/s/ MARC HEDRICK | ||
Additional Account Owner | ||
Print Name | Date | |
Signature | ||
X | ||
Please Complete if a Trust, Corporation, Partnership, or Other Entity | ||
Print Name of Entity PLUS THERAPEUTICS INC | Date 05-24-2024 | |
Title CFO | ||
Signature | ||
/s/ ANDREW SIMS |
FOR BROKER-DEALER USE ONLY |
The information below must be submitted for all LoanAdvance accounts, regardless of which interest rate index is selected. In addition, by signing below, the Branch Manager acknowledges that they have provided the Borrower with the Broker-Dealers tiered interest rate schedule, if applicable.
Print Branch Manager Name |
Date | |
Signature | ||
X |
© 2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners. | PAGE 2 OF 2 FRM-LA-DIS-ACK-10-21 |